HIV/AIDS continues to be the pandemic of our times. It is estimated that 36 to 45 million people including 2-3 million children already are infected worldwide and an additional 4-7 million more are infected each year. There has not been a comprehensive medically based AIDS prevention book published in the last five years. Since that time many new program interventions have been tried and much has been learned through evidence-based research. HIV Prevention will place special focus on the array of interventions that have been proven effective through rigorous study. If there is one theme that has been learned to date it is that there is no one-size-fits-all prevention approach that will work in all the geographic, demographic and socio-cultural environments impacted by the worldwide AIDS pandemic.

IntroductionI. Section I: Contexts and Principles: epidemiology, applied virology, microbiology, infectious disease and behavioural psychology applied to the design of AIDS prevention interventions Chapter 1: Current And Future Trends: Implications For PreventionChapter 2. Biology of HIV TransmissionChapter 3: Principles and Theories of Behavior Applied to HIV PreventionII. Section II: Evidence-Based Prevention Interventions: programs for at-risk populations Chapter 4. Individual InterventionsChapter 5. Dyadic and Group InterventionsChapter 6. Structural Interventions in Societal ContextsChapter 7: Voluntary Counselling and TestingChapter 8: Interventions With Men Who Have Sex With MenChapter 9. Interventions With Injecting Drug UsersChapter 10: Interventions With Sex WorkersChapter 11: Interventions With Youth in High Prevalence AreasChapter 12: Interventions With Incarcerated and Institutionalized PersonsChapter 13. Preventing Perinatal Transmission III. Policy, Technology and Research: Biomedical technologies for prevention, testing and researchChapter 14. Harm Reduction and Public Health Chapter 15. STD Control for HIV PreventionChapter 16 Using Antiretrovirals to Prevent HIV TransmissionChapter 17 MicrobicidesChapter 18 VaccinesChapter 19. Program Monitoring and Evaluation